Actinium Pharmaceuticals Inc. (Delaware) (ATNM) director Steinhart received 62,800 shares
Insider transactions reported
Richard I Steinhart (director at Actinium Pharmaceuticals Inc. (Delaware), ATNM) reported that they received 62,800 shares on Sep 2, 2026. After these transactions the filing shows 63,116 shares held directly.
- Reporting person
- Steinhart Richard I
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Grant or award (A) | Common Stock1 | +62,800 | - | - | 63,116 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Grant or award (A) | Stock Option (Right to Buy)On 94,200 Common Stock2 | +94,200 | - | - | 94,200 direct |
Holdings before and after
- Common Stock: 316 to 63,116 direct
- Stock Option (Right to Buy): 0 to 94,200 direct
Footnotes from the filing
- 1. Represents a grant of restricted stock units ( RSUs ). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
- 2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Steinhart report in this ATNM Form 4?
Richard I Steinhart (director at Actinium Pharmaceuticals Inc. (Delaware), ATNM) reported that they received 62,800 shares on Sep 2, 2026. After these transactions the filing shows 63,116 shares held directly.
How many ATNM shares does Steinhart hold after this filing?
The filing shows 63,116 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ATNM
Across the 13 sessions after earlier ATNM headlines, the stock closed higher 4 times and lower 9 times, with a median move of 4.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
Earlier insider filings at ATNM
- Sep 4, 2026Chief Executive Officer Seth Sandesh was granted 1,780,874 shares, increasing direct ownership by 965% to 1,965,355 units (SEC Form 4)
- Sep 4, 2026Director Almenoff June Sherie was granted 18,000 shares (SEC Form 4)
- Sep 4, 2026Director Shetty Ajit was granted 61,600 shares, increasing direct ownership by 8,137% to 62,357 units (SEC Form 4)
- Aug 20, 2025Chief Executive Officer Seth Sandesh covered exercise/tax liability with 120,900 shares, decreasing direct ownership by 40% to 184,481 units (SEC Form 4)
- Apr 2, 2025SEC Form 4 filed by Director Steinhart Richard I
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow ATNM and get a push notification the moment its next story breaks.